Skip to main content

1.

1

Evaluating the functional integrity of natural killer (NK) cell in triple-negative breast cancer (TNBC) patients. (A) Gating strategy for NKG2A (CD159a); (B) Gating strategy for NKG2D (CD314); (C) Comparing the proportion of total NK cell, NKG2A positive NK cell and NKG2D positive NK cell between health control and TNBC.